Chronic skin-specific inflammation promotes vascular inflammation and thrombosis
- PMID: 22572815
- PMCID: PMC3402600
- DOI: 10.1038/jid.2012.112
Chronic skin-specific inflammation promotes vascular inflammation and thrombosis
Abstract
Patients with psoriasis have systemic and vascular inflammation and are at increased risk for myocardial infarction, stroke, and cardiovascular death. However, the underlying mechanism(s) mediating the link between psoriasis and vascular disease is incompletely defined. This study sought to determine whether chronic skin-specific inflammation has the capacity to promote vascular inflammation and thrombosis. Using the KC-Tie2 doxycycline-repressible (Dox-off) murine model of psoriasiform skin disease, spontaneous aortic root inflammation was observed in 33% of KC-Tie2 compared with 0% of control mice by 12 months of age (P=0.04) and was characterized by the accumulation of macrophages, T lymphocytes, and B lymphocytes, as well as by reduced collagen content and increased elastin breaks. Importantly, aortic inflammation was preceded by increases in serum tumor necrosis factor-α, IL-17A, vascular endothelial growth factor, IL-12, monocyte chemotactic protein-1, and S100A8/A9, as well as splenic and circulating CD11b(+)Ly-6C(hi) pro-inflammatory monocytes. Doxycycline treatment of old mice with severe skin disease eliminated skin inflammation and the presence of aortic root lesion in 1-year-old KC-Tie2 animals. Given the bidirectional link between inflammation and thrombosis, arterial thrombosis was assessed in KC-Tie2 and control mice; mean time to occlusive thrombus formation was shortened by 64% (P=0.002) in KC-Tie2 animals; and doxycycline treatment returned thrombosis clotting times to that of control mice (P=0.69). These findings demonstrate that sustained skin-specific inflammation promotes aortic root inflammation and thrombosis and suggest that aggressive treatment of skin inflammation may attenuate pro-inflammatory and pro-thrombotic pathways that produce cardiovascular disease in psoriasis patients.
Figures
Similar articles
-
Protection from Psoriasis-Related Thrombosis after Inhibition of IL-23 or IL-17A.J Invest Dermatol. 2018 Feb;138(2):310-315. doi: 10.1016/j.jid.2017.09.021. Epub 2017 Sep 23. J Invest Dermatol. 2018. PMID: 28951241 Free PMC article.
-
Chronic, not acute, skin-specific inflammation promotes thrombosis in psoriasis murine models.J Transl Med. 2015 Dec 16;13:382. doi: 10.1186/s12967-015-0738-z. J Transl Med. 2015. PMID: 26675482 Free PMC article.
-
Depletion of antigen-presenting cells by clodronate liposomes reverses the psoriatic skin phenotype in KC-Tie2 mice.Br J Dermatol. 2011 Apr;164(4):750-8. doi: 10.1111/j.1365-2133.2010.10129.x. Br J Dermatol. 2011. PMID: 21070202 Free PMC article.
-
Role of IL-17A signalling in psoriasis and associated bone loss.Clin Exp Rheumatol. 2016 Jul-Aug;34(4 Suppl 98):17-20. Epub 2016 Jul 20. Clin Exp Rheumatol. 2016. PMID: 27586798 Review.
-
Thrombosis in Psoriasis: Cutaneous Cytokine Production as a Potential Driving Force of Haemostatic Dysregulation and Subsequent Cardiovascular Risk.Front Immunol. 2021 Jul 16;12:688861. doi: 10.3389/fimmu.2021.688861. eCollection 2021. Front Immunol. 2021. PMID: 34335591 Free PMC article. Review.
Cited by
-
Laboratory and clinical haemostatic aberrations in primary dermatologic disease: A review.Thromb J. 2024 Nov 12;22(1):101. doi: 10.1186/s12959-024-00665-w. Thromb J. 2024. PMID: 39533305 Free PMC article. Review.
-
Cardiovascular comorbidities among patients with psoriasis: a national register-based study in China.Sci Rep. 2024 Aug 24;14(1):19683. doi: 10.1038/s41598-024-70707-w. Sci Rep. 2024. PMID: 39181937 Free PMC article.
-
Human skin bacterial microbiota homeostasis: A delicate balance between health and disease.mLife. 2023 Jun 4;2(2):107-120. doi: 10.1002/mlf2.12064. eCollection 2023 Jun. mLife. 2023. PMID: 38817619 Free PMC article. Review.
-
The role of the skin microbiome in wound healing.Burns Trauma. 2024 Mar 4;12:tkad059. doi: 10.1093/burnst/tkad059. eCollection 2024. Burns Trauma. 2024. PMID: 38444635 Free PMC article. Review.
-
Specialist and Patient Perspectives on Strategies to Improve Cardiovascular Disease Prevention Among Persons Living with Psoriatic Disease.J Psoriasis Psoriatic Arthritis. 2022 Oct;7(4):174-186. doi: 10.1177/24755303221101848. Epub 2022 Jun 3. J Psoriasis Psoriatic Arthritis. 2022. PMID: 38148879 Free PMC article.
References
-
- Ahlehoff O, Gislason GH, Jorgensen CH, Lindhardsen J, Charlot M, Olesen JB, et al. Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study. Eur Heart J. 2011a - PubMed
-
- Alexandroff AB, Pauriah M, Camp RD, Lang CC, Struthers AD, Armstrong DJ. More than skin deep: atherosclerosis as a systemic manifestation of psoriasis. Br J Dermatol. 2009;161:1–7. - PubMed
-
- Balci DD, Balci A, Karazincir S, Ucar E, Iyigun U, Yalcin F, et al. Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis. J Eur Acad Dermatol Venereol. 2009;23:1–6. - PubMed
-
- Baldus S, Heeschen C, Meinertz T, Zeiher AM, Eiserich JP, Munzel T, et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation. 2003;108:1440–1445. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- HL73852/HL/NHLBI NIH HHS/United States
- P30 AR039750/AR/NIAMS NIH HHS/United States
- R01 HL085816/HL/NHLBI NIH HHS/United States
- HL85816/HL/NHLBI NIH HHS/United States
- P50 AR055508-05/AR/NIAMS NIH HHS/United States
- P50 AR055508/AR/NIAMS NIH HHS/United States
- R01 HL073852-04/HL/NHLBI NIH HHS/United States
- R01 HL073852/HL/NHLBI NIH HHS/United States
- R01 HL085816-04/HL/NHLBI NIH HHS/United States
- HL57506/HL/NHLBI NIH HHS/United States
- P30AR39750/AR/NIAMS NIH HHS/United States
- R37 HL057506-16/HL/NHLBI NIH HHS/United States
- R01 HL057506/HL/NHLBI NIH HHS/United States
- P50AR05508/AR/NIAMS NIH HHS/United States
- R37 HL057506/HL/NHLBI NIH HHS/United States
- P30 AR039750-22/AR/NIAMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous